e-learning
resources
Paris 2018
Sunday, 16.09.2018
Challenges in treating tuberculosis and nontuberculous mycobacteria
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Video observed treatment for tuberculosis patients in Belarus.
A. Skrahina (Minsk, Belarus), H. Sinkou (Minsk, Belarus), V. Akulov (Minsk, Belarus), V. Grankov (Minsk, Belarus), A. Story (London, United Kingdom), H. Hurevich (Minsk, Belarus), M. Dara (Copenhagen, Denmark)
Source:
International Congress 2018 – Challenges in treating tuberculosis and nontuberculous mycobacteria
Session:
Challenges in treating tuberculosis and nontuberculous mycobacteria
Session type:
Poster Discussion
Number:
529
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Skrahina (Minsk, Belarus), H. Sinkou (Minsk, Belarus), V. Akulov (Minsk, Belarus), V. Grankov (Minsk, Belarus), A. Story (London, United Kingdom), H. Hurevich (Minsk, Belarus), M. Dara (Copenhagen, Denmark). Video observed treatment for tuberculosis patients in Belarus.. 529
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Video observed treatment for tuberculosis patients in Belarus
Source: International Congress 2017 – MDRTB: detection and management
Year: 2017
Video observed treatment for TB patients. Belarus experience.
Source: Virtual Congress 2020 – Multidrug-resistant tuberculosis
Year: 2020
Belarus experience in video observed treatment for tuberculosis patients
Source: International Congress 2019 – Tuberculosis: a public health approach
Year: 2019
The cost of treatment of tuberculosis in children of Belarus
Source: Virtual Congress 2020 – How do different treatment strategies translate into costs
Year: 2020
Multidrug-resistance tuberculosis and HIV-infected patients, the effectiveness of the treatment in Ukraine
Source: Annual Congress 2010 - Tuberculosis drug resistance
Year: 2010
The results of the antituberculosis treatment to the patients with pulmonary tuberculosis in Bucharest (Romania) in 2001
Source: Annual Congress 2003 - Management of tuberculosis and tubercular infection - old and new considerations
Year: 2003
TB detection in children in Moscow (Russia) as in low TB incidence region
Source: International Congress 2018 – Groups who are susceptible to tuberculosis: children, pregnant women and elderly people
Year: 2018
Untimely found TB cases and causes of death among patients infected with HIV/TB and with TB alone in the Leningrad region
Source: Annual Congress 2010 - Tuberculosis in special populations
Year: 2010
Recurrent tuberculosis among HIV-infected patients in Novokuznetsk, Russia.
Source: International Congress 2019 – Tuberculosis: from diagnosis to complications
Year: 2019
Video-observed treatment for tuberculosis patients in Belarus: findings from the first programmatic experience
Source: Eur Respir J , 49 (3) 1602049; DOI: 10.1183/13993003.02049-2016
Year: 2017
Treatment outcomes and deaths among multidrug-resistant tuberculosis (MDR-TB) patients in Gomel region, Belarus – 2009-2010
Source: Annual Congress 2013 –Drug-resistant tuberculosis: new clinical and public health insights
Year: 2013
High completion rates with directly observed preventive treatment (DOPT) of latent tuberculosis infection (LTBI) in Ethiopian immigrants (EI) to Israel
Source: Annual Congress 2012 - Tuberculous and non-tuberculous mycobacterial infections: epidemiology I
Year: 2012
Comparison of two different cohorts of patients for multidrug-resistant tuberculosis treatment evaluation
Source: Annual Congress 2006 - Epidemiology and management of multidrug-resistant tuberculosis (MDR-TB)
Year: 2006
When do we extend the treatment of tuberculosis (TB) more than 6 months?
Source: Annual Congress 2007 - Clinical tuberculosis
Year: 2007
One year follow-up of T-SPOT. TB results in treated patients with active tuberculosis
Source: Annual Congress 2007 - New perspectives and old problems in diagnosing tuberculosis infection and disease
Year: 2007
Active tuberculosis in children in close contact with smear-positive cases of pulmonary tuberculosis in Sofia (Bulgaria) during the period 2007-2009
Source: Annual Congress 2010 - Tuberculosis in children
Year: 2010
The peculiarities of histological diagnostic of tuberculosis (TB) in HIV-infected patients in Ukraine
Source: Eur Respir J 2006; 28: Suppl. 50, 20s
Year: 2006
Treatment outcomes of tuberculosis patients under directly observed therapy (DOT) for three years
Source: Eur Respir J 2004; 24: Suppl. 48, 653s
Year: 2004
Treatment results in patients with XDR tuberculosis in Ukraine
Source: Eur Respir J 2007; 30: Suppl. 51, 272s
Year: 2007
Differences in the manegement of latent tuberculosis infection in patients treated with anti-TNF-α in Turkey
Source: Annual Congress 2012 - Tuberculous and non-tuberculous mycobacterial infections: epidemiology II
Year: 2012
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept